Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioAtla, Inc. | 321,550 | reported | 18 Jun 2025 | tx 59+835,801−106,413 |
| Viatris Inc | 256,074 | reported | 06 Mar 2026 | tx 46+4,740,079−2,865,884.86 |
| TITAN PHARMACEUTICALS INC | 10,000 | reported | 15 Sept 2017 | tx 1+10,000 |
| Spring Bank Pharmaceuticals, Inc. | 7,500 | reported | 24 Jun 2020 | tx 8+63,476 |
| Brookline Capital Acquisition Corp. | 0 | reported | 23 Aug 2023 | tx 3+100,000−134,084 |
| CELGENE CORP /DE/ | 0 | reported | 17 Feb 2018 | tx 53+309,875−95,429 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 2,433 | 14.16 USD | |
| 06 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 48,999 | 14.16 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 6,182 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 124,519 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 124,519 | 0.00 USD | deriv |
| 06 Mar 2026 | GRANT_AWARD | Viatris Inc | 256,074 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 6,181.42 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 135,828 | 0.00 USD | |
| 03 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 53,449 | 14.89 USD | |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 18,154 | 0.00 USD | |
| 03 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 7,144 | 14.89 USD | |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 1,286,849 | 0.00 USD | |
| 03 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 506,376 | 14.89 USD | |
| 04 Mar 2026 | EXERCISE | Viatris Inc | 92,503 | 0.00 USD | |
| 04 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 3,429 | 14.71 USD | |
| 04 Mar 2026 | EXERCISE | Viatris Inc | 8,714 | 0.00 USD | |
| 04 Mar 2026 | TAX_WITHHOLDING | Viatris Inc | 36,400 | 14.71 USD | |
| 04 Mar 2026 | EXERCISE | Viatris Inc | 8,713.65 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 135,828 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 18,153.2 | 0.00 USD | deriv |
| 04 Mar 2026 | EXERCISE | Viatris Inc | 92,503 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viatris Inc | 1,286,849 | 0.00 USD | deriv |
| 03 Mar 2026 | GRANT_AWARD | Viatris Inc | 1,286,849 | 0.00 USD | deriv |
| 12 Aug 2025 | PURCHASE | Viatris Inc | 22,000 | 9.99 USD | |
| 18 Jun 2025 | GRANT_AWARD | BioAtla, Inc. | 23,500 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 12 May 2025.